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Recent recommendations for the prophylaxis of endocarditis in humans have advocated
singledoses or short courses of antibiotic combinations (f3-lactam plus aminoglycoside)
for susceptible patients in whom enterococcal bacteremia might develop or for patients
at especially high risk of developing endocarditis (e.g., patients with prosthetic cardiac
valves). Wetested the prophylactic efficacy (in rats with catheter-induced aortic vegeta-
tions) of singledoses of amoxicillinplus gentamicin against challenge with various strep-
tococcal strains (two strains of Streptococcus faecalis, one of Streptococcus bovis, and
three of viridans streptococci); we then compared this efficacy with that of single doses
of amoxicillinalone. Successfulprophylaxis against all six strains was achievedwith sin-
gledoses of both amoxicillin alone and amoxicillin plusgentamicin.This protection, how-
ever, was limited, for both regimens, to the lowestbacterial-inoculum size producing en-
docarditis in 90% of control rats and was not extended to higher inocula by using the
combination of antibiotics. We concluded that a single dose of amoxicillin alone was
protective against enterococcal and nonenterococcal endocarditis in the rat, but that its
efficacy was limited and could not be improved by the simultaneous administration of
gentamicin.
Recommendations of the American Heart Associa-
tion for antibiotic prophylaxis of bacterial en-
docarditis are partly based on studies in rabbits [1].
In these experiments the bacterial inocula used for
inducing endocarditis were very high; probably one
or several logs higher than the minimum inocula
necessary to induce endocarditis in 90010 of untreated
animals (ID 90) [2, 3]. Under these circumstances, only
high and prolonged levels of bactericidal antibiot-
ics were effective in preventing endocarditis. Hence,
recommendations for the prophylaxis of endocarditis
in humans have advocated multiple doses of bacteri-
cidal antibiotics or combinations of antibiotics.
These recommendations have been somewhat cum-
bersome and often difficult to comply with, both
for physicians and for patients.
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Because it has been argued that high inocula are
not relevant to clinical situations [4], recent experi-
ments in rats have analyzed in detail the role of the
size of the bacterial inoculum used to induce en-
docarditis on the effectiveness of prophylactic anti-
biotics. By using various strains of streptococci that
commonly cause endocarditis, it was found that var-
ious antibiotics (including amoxicillin, penicillin, and
even bacteriostatic antibiotics such as clindamycin
or erythromycin), given as single doses, were effec-
tive in preventing endocarditis, provided that the in-
oculum size used to induce endocarditis was not
higher than the ID 90 [5, 6]. Recently, recommenda-
tions for the prophylaxis of endocarditis using sin-
gle doses of antibiotics in humans have emerged [7].
Although these recommendations are obviously
more practical than those for multiple doses, it is
not known whether they are appropriate.
To improve the efficacy of the single dose regi-
mens, the use of combinations of antibiotics instead
of a single drug has been proposed, particularly when
enterococci are considered to be potential pathogens
[7] (fJ-lactam antibiotics are only bacteriostatic
against these bacteria unless combined with an
aminoglycoside [8]). The purpose of the present ex-
periments was to compare the efficacy of single doses
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of amoxicillin with that of the combination of amox-
icillin and gentamicin.
Materials and Methods
Microorganisms. Six strains of streptococci were
used for these experiments; all were isolated from
patients with endocarditis. Three strains were group
D streptococci: two were identified as Streptococcus
faecalis (nos. 309 and 1209)and one as Streptococcus
bovis. Three strains were of the viridans group and
were identified as Streptococcus mitis, Streptococcus
intermedius, and Streptococcus sanguis (the latter
two strains have been used in previous experiments
[5, 6]).
Determination ofMICs, MBCs, andrates ofkill-
ing. The MICs of amoxicillin and of gentamicin
were determined for the six microorganisms by using
a standard broth-dilution technique with an inocu-
lum of 106 organisms from an overnight culture [9].
The MBCs were determined by subculturing on
blood-agar plates supplemented with penicillinase
(Difco Laboratories, Detroit) lO-fold and 100-fold
broth dilutions of a OJ-ml sample from each dilu-
tion of antibiotic showing no turbidity after 18 hr
of incubation. This dilution procedure, before sub-
culturing for MBC determination, was used to avoid
the carryover of antibiotic, a phenomenon that can
give falsely low MBCs. After incubation for 48 hr,
the number of colonies from each subculture on
blood-agar plates was counted and the MBC deter-
mined as the lowest dilution of antibiotic that showed
99.90/0 killing.
Using concentrations of 25 f-lg of amoxicillin/ml
or 8 f-lg of gentamicin/ml or both, we determined
the rates of killing of the six strains in tryptic soy
broth (Difco) by using a 106 inoculum from an over-
night culture. Concentrations of 25 f-lg of amoxicil-
lin/ml and of 8 1Jg of gentamicin/ml were chosen
because they were similar to serum levels achieved
in rats 30 min after the iv injection of 40 mg of amox-
icillin/kg and 4 mg of gentamicin/kg. In man, these
serum levels are achieved 2 hr after an oral dose of
3 g of amoxicillin [10] and 30 min after an iv dose
of 1.5 mg of gentamicin/kg [11]. Against S. bovis,
a concentration of 2 1Jg of gentamicin/ml was used
because the strain was killed too rapidly by 8 1Jg/ml
to allow the demonstration of synergism when the
gentamicin was combined with amoxicillin. At var-
ious times after the inoculation of bacteria into the
antibiotic-containing broth, 10-1, 10-3 , and 10-5 di-
lutions of a OJ-ml sample weresubcultured on blood-
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agar plates containing penicillinase and were in-
cubated for 48 hr for colony counts.
Serum levels ofantibiotics and serum bacterici-
dal activity. Serum levels at 30 min, 1, 2, and 4 hr
after injection of various iv doses of amoxicillin or
gentamicin to groups of five rats were determined
by the standard agar-diffusion technique with Ba-
cillus subtilis as the test organism and normal rat
serum as diluent [12]. The serum bactericidal activ-
ity 30 min, 1,2, and 4 hr after the iv administration
of amoxicillin (or amoxicillin plus gentamicin) to rats
were determined for each strain by standard methods
with a lOS inoculum of an overnight culture [13]. The
serum bactericidal activity was defined as the highest
serum dilution providing 99.90/0 killing after 18 hr
of incubation.
Production ofendocarditis and evaluation ofin-
fection. Sterile vegetations wereproduced in female
Wistar rats. (180-200 g) by a modification of a
method already described [14]. Briefly, a polyethyl-
ene catheter (PP 10; Portex, Hythe, Kent, England)
was inserted across the aortic valve through the right
carotid artery and secured with a silk ligature.
Twenty-four hours after catheterization rats were in-
jected in the tail vein with 0.5 ml of saline contain-
ing various inocula (confirmed by colony counts and
expressed in cfu) from overnight cultures of the test
microorganisms. Rats were killed 72 hr thereafter,
and aortic vegetations were excised, weighed, homo-
genized in 1 ml of saline, serially diluted, and plated
on blood-agar plates containing penicillinase. Plates
were counted after 48 hr of incubation at 37 C. This
method permitted the detection of 102 cfu/g of'vege-
tation.
Prophylaxis of endocarditis with amoxicillin or
withamoxicillin plus gentamicin. For each inocu-
lum size equal to or greater than the ID 90 of a par-
ticular strain tested, 30-40 rats weredivided into three
groups: the first group received 40 mg of amoxicil-
lin alone /kg (iv) 30 min before bacterial challenge;
the second group received the combination of amox-
icillin and 4 mg of gentamicin/kg (im); and the con-
trol group received saline (iv).
Statistical evaluation. The X2 test with Yates's
correction and the unpaired Student's t test wereused
for statistical comparisons.
Results
Minimum inhibitoryand bactericidal concentra-
tions. The MICs and MBCs of amoxicillin for the
six test organisms are shown in table 1. All strains
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Table 1. MICs and MBCs of the six test organisms.
Amoxicillin Gentamicin
Strains MIC MBC MIC MBC
S. faecalis 309 1 >128 32 64
S. faecalis 1209 1 >128 4 16
S. bovis 0.032 >128 1 2
S. mitis 0.016 >128 16 32
S. intermedius 0.125 >128 4 8
S. sanguis 0.008 16 8 32
NOTE. Results are Ilg of the antibiotic/ml.
had high MBCs, a phenomenon that is common
among streptococci when careful measures are taken
to avoid the carryover of antibiotics (P. Meylan,
P. E, and M. P. G., unpublished observations; [15]).
Serum levels ofamoxicillin and ofgentamicin in
rats. Following the iv administration of various
doses of amoxicillin, it was found that 40 mg/kg gave
a mean peak serum level (± SD) of 23.7 ± 3.0
ug/ml at 30 min. This level was similar to those
achieved in humans following an oral dose of 3 g
of amoxicillin [10]. The mean values (± SD) at 1,
2, 4, and 6 hr after iv injection into five rats were
8.8 ± 1.0J,tg/ml, 3.5 ± 0.4 ug/ml, 0.6 ± 0.3 ug/ml,
and zero, respectively.
Following the im administration of 4 mg of gen-
tamicin/kg, serum levels (± SD) were 8.0 ± 2.1
ug/ml, 4.6 ± 1.8 ug/ml, 1.9 ± 0.9 ug/ml, and zero,
30 min, 1, 2, and 4 hr after injection, respectively.
Serum bactericidal activities. Following the iv
administration of 40 mg of amoxicillin/kg to rats,
no serum bactericidal activities (five determinations)
against any of the six strains of streptococci could
be detected 30 min or later after injection. After ad-
ministration of a combination of amoxicillin (40
mg/kg) and gentamicin (4 mg/kg), the serum bac-
tericidal activities (mean of five determinations)
against the three group D strains were 1:8, 1:4, and
undetectable, at 30 min, 2, and 4 hr, respectively.
Against the three viridans strains, they were 1:4, 1:2,
and undetectable at the same time points.
Ratesofkillingofthe six teststrains. With con-
centrations of 8 J,tg of gentamicin alone/ml, only the
S. bovis inoculum was killed in 6 hr, the remaining
five strains showed >100010 survival of the inoculum
at 24 hr. Using 2 jAg of gentamicin/ml against
S. bovis, we observed no significant killing over 24
hr. Figure 1 represents the rates of killing of the six
strains by 25 jAg of amoxicillin /ml with and without
the addition of 8 J,tg of gentamicin (2 J,tg of gentami-
cin for S. bovis). The figure shows that no signifi-
cant killing occurred during the first 6 hr of exposure
to amoxicillin for any of the six strains. As with gen-
tamicin alone, no strain was killed upon 24 hr of ex-
posure to amoxicillin. In contrast, when exposed to
25 J,t;; of amoxicillin/ml and 8 J,tg of gentamicin/ml
(2 jA.;/ml for S. bovis), killing of more than 99.9010
of the inoculum (which defines the MBC and the
serum bactericidal activity) was achieved in less than
6 hr for the six strains, thus demonstrating syner-
gism upon exposure to the combination of amox-
icillin and gentamicin at this time point. It took more
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Figure 1. Rates of in vitro killing of
six streptococcal strains by 25 /lg of
amoxicillin alone (amoxi)/ml or in
combination with 8 /lg of gentamicin
(genta)/ml. CD S. faecalis 309; ®
S. faecalis 1209; ® S. bovis; ®
S. mitis; @ S. sanguis; and ®
S. intermedius.
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Figure 2. Incidence of endocarditis in control (C) rats and in rats treated with amoxicillin (A) or amoxicillin +
gentamicin (A + G) three days after bacterial challenge with various inocula of six streptococcal strains. The total
number of rats per group is indicated at the base of each column. P valueswere calculated by x2 analysis with Yates's
correction; the cross symbolizes P < .05.
than 6 hr, however, for the combination of antibiot-
ics to achieve sterility with five of the six strains.
Natural history ofstreptococcalendocarditis and
prophylaxis with amoxicillin and gentamicin, alone
or in combination. As shown in figure 2, the inci-
dence of endocarditis in control rats increased with
the inoculum size of each strain used for challenge.
The ID 90 varied according to the strain tested; it was
104 cfu for the two S. faecalis strains, 105 cfu for
S. intermedius and S. bovis, and 106 cfu for S. sanguis
and S. mitis. With these inoculum sizes, amoxicillin
alone completely prevented endocarditis. With in-
ocula 10 times higher than the ID 9o , significant but
insufficient protection was still observed, but for only
two of the six strains (S. faecalis 309 and S. mitis).
With greater inocula, the prophylactic effect was
overcome for all six strains. Despite in vitro syner-
gism and increased serum bactericidal activity after
simultaneous administration, the association of
amoxiciIIin and gentamicin was not more effective
than amoxiciIIin alone in preventing endocarditis
caused by four of the six strains. For S. sanguis and
S. bovis, the combination of the antibiotics was mar-
ginally better than amoxiciIIin alone.
Discussion
Recently, single doses of antibiotics like amoxicillin
have been shown to be very effective in preventing
experimental streptococcal endocarditis, provided
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that the inoculum sizes used to induce the bacter-
emia werenot higher than the lowest inoculum capa-
ble of producing endocarditis in 90% of control
animals [6J. Moreover, the protection conferred by
antibiotics occurred in the absence of bacterial kill-
ing [6]. Indeed, even bacterostatic antibiotics like
clindamycin and erythromycin were very effective in
preventing endocarditis [5]. It was therefore of in-
terest to investigate the efficacy of single doses of
amoxicillin in preventing endocarditis induced by
S. faecalis, a species of organism for which f3-lactam
antibiotics are known to be only bacteriostatic [8].
These experiments were performed in comparison
with other streptococci, including three strains of the
viridans group and one strain of S. bovis, which, like
the enterococci, originate from the gut flora but dif-
fer from S. faecalisby their antibiotic susceptibility.
The results of the present experiments show that
a single dose of amoxicillin alone prevented en-
terococcal endocarditis as effectively as it did nonen-
terococcal streptococcal endocarditis, provided that
the inoculum used for challenge was not higher than
ID90 for each strain tested. It should be noted, how-
ever, that the ID90 of the two S. faecalis strains were
lO-I00-fold lower than were the ID90 of the four other
streptococcal strains tested, thus showing that the
protection conferred by a single dose of amoxicillin
against endocarditis caused by S. faecalis was limited
to inocula of a lesser magnitude. This might explain
why single doses of ampicillin alone were not effec-
tive in prior experiments in rabbits for the prophy-
laxis of enterococcal endocarditis in which the
animals were challenged with only very high inoc-
ula [16].
It was remarkable that the protection observed in
the present experiments occurred despite the absence
of killing against the six strains tested, both in vitro
and in vivo. Indeed, the killing curves showed that
no strains were killed after 24 hr of incubation in
concentrations of amoxicillin similar to peak con-
centrations obtained in humans after oral adminis-
tration of a 3-g dose. Moreover, there was no serum
bactericidal activity detectable at the time of injec-
tion of the bacteria. Therefore, the present results
that demonstrate the prophylactic efficacy of amox-
icillin despite the absence of significant killing con-
firm our previous results with viridans streptococci
[5, 6] and extend these observations to group D strep-
tococci, especially to S. faecalis. Tolerance to the bac-
tericidal action of cell wall-active antibiotics is not
only a characteristic of S. faecalis but also appears
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to be a common finding among viridans streptococci
isolated from patients with endocarditis. Indeed,
among 25 viridans strains isolated from such pa-
tients, 17 were shown to be tolerant to amoxicillin
(MBC/MIC ratio >32) and 13 (50070) had MBCs
>32 ug/ml [15].
In the prophylaxis of endocarditis, experiments
in rabbits [16, 17] have suggested that single doses
of synergistic combinations of antibiotics might be
more effective than a single dose of a single antibi-
otic in preventing streptococcal endocarditis, both
of the viridans and of the enterococcal groups. This
apparently contradicts the present experiments, in
which single doses of the combination of amoxicil-
lin and gentamicin were not superior to amoxicillin
alone for four of the six strains tested and were only
marginally better for the other two strains tested.
Several factors can account for these differences.
First, in the rabbit experiments mentioned above, in
which a single dose of ampicillin alone was ineffec-
tive in the prevention of enterococcal endocarditis,
the combination of ampicillin and gentamicin was
not uniformly efficacious; it was protective against
only two of the four strains tested in detail [16]. Simi-
larly, Guze et al. (18] found that three doses of the
combination of ampicillin and gentamicin were not
superior to ampicillin alone for two of the four
strains tested and were only marginally better for the
other two strains. Thus the combination of ampicil-
lin and gentamicin, given either as single doses or
even as short courses (three doses), were not relia-
bly superior to ampicillin alone in preventing en-
terococcal endocarditis in rabbits.
Second, our previous [6] and present experiments
have stressed the critical role of the size of the bac-
terial inoculum used for testing the efficacy of anti-
biotics. This is not only well illustrated by the suc-
cess of antibiotic prophylaxis at or around the ID9o ,
but also by its failure when the inoculum size is in-
creased. Thus, in order to compare different prophy-
lactic antibiotic regimens, it appears crucial that ex-
periments be devised in which groups of animals
treated with the various prophylactic regimens be
simultaneously challenged with each inoculum size
of the strain tested. This caution might not have been
taken in the rabbit experiments and might explain
some of the discrepancies between our results and
the results of others.
Third, previous experiments in rats [6] have shown
that protection against endocarditis is independent
of the inoculum size only when the mechanism of
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protection is likely to be bacterial killing. This can
occur when the bacteria are sensitive enough to the
bactericidal action of the antibiotic that they are
killed during the time they are exposed to the an-
tibiotic in vivo. In the present experiments, it is un-
likely that the combination of amoxicillin and gen-
tamicin, despite its in vitro synergism against all six
strains, killed the organisms fast enough in vivo to
extend protection to inocula higher than the ID90 •
Indeed, it took ~6 hr for the antibiotic combination
to kill all six strains in vitro, whereas serum levels
of both antibiotics and bactericidal activities in vivo
were undetectable by 6 hr. In contrast, experiments
with S. sanguis in rabbits have been performed with
procaine-penicillin G, which, at 6 hr, produced se-
rum levels as high as 3.4 J.Lg/ml and produced high
bactericidal titers when combined with streptomy-
cin [17]. Thus, pharmacokinetic differences of anti-
biotics in rat and in rabbit experiments might be ad-
ditional factors that explain the different results
observed between our experiments and those of
others.
The mechanisms by which antibiotics afforded
protection in the present observations are not clear.
Experiments from different laboratories have
demonstrated that protection against endocarditis
might occur in the absence of bacterial killing and
suggested that other mechanisms of protection, such
as inhibition of bacterial adherence onto damaged
valves, might playa role [6, 19-21]. This may also
be the case in the present experiments, which showed
that amoxicillin inhibited the in vitro adhesion to
platelet-fibrin matrices of all strains tested, includ-
ing the two enterococcal strains (data not shown).
Inhibition of bacterial adherence conferred by amox-
icillinalone was not enhanced by the addition of gen-
tamicin for three of the four streptococcal strains
tested (data not shown). Therefore, if inhibition of
adherence was a mechanism by which antibiotics
protected against endocarditis, one could have
predicted from in vitro adhesion experiments that
the combination of amoxicillin and gentamicin
would not be more effective than amoxicillin alone
in vivo, a prediction confirmed in the present rat ex-
periments.
In conclusion, in our model single doses of amox-
icillin wereas effective in preventing enterococcal en-
docarditis as they werein preventing endocarditis due
to various streptococcal strains. Protection, however,
was limited to inocula of moderate size, especially
for S. faecalis, and was probably not conferred by
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killing of the bacteria. Single doses of the synergis-
tic combination of amoxicillin and gentamicin were
not more effective in preventing endocarditis than
was amoxicillin alone, probably because the combi-
nation did not kill the bacteria used for challenge
in this model rapidly enough to be operative by this
mechanism.
Certain authors [7] recommend single doses of
amoxicillin for the prevention of streptococcal en-
docarditis, combining it with a single dose of an
aminoglycoside for high-risk patients. The present
experiments, as wellas other recent studies [6], show
that a single dose of amoxicillin is effective in
preventing experimental streptococcal, including en-
terococcal, endocarditis. Our data suggest, however,
that a single dose of a synergistic combination of
antibiotics might not be significantly more effective
than a single dose of amoxicillin alone. Recent ex-
periments in rats have confirmed previous studies
in rabbits by Durack et al. [2] and by Pelletier et al.
[3] and have shown that only multiple doses of a
combination of antibiotics given for at least 48 hr
can ensure inoculum-independent protection [22].
Therefore, patients in whom the development of bac-
terial endocarditis would be disastrous (e.g., patients
with prosthetic valves) might benefit from multiple
doses of a combination of antibiotics to minimize
the risk of subsequent endocarditis. Similar regimens
might also be recommended when one intends to pre-
vent endocarditis caused by S. jaecalis, because the
capacity of these organisms to induce endocarditis
appears particularly high in view of the low 1090 ;
a single dose of an antibiotic or of a combination
of antibiotics might not provide a sufficient margin
of safety even for a patient at moderate risk of de-
veloping endocarditis.
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